Reshape Lifesciences Stock Price History

RSLS Stock  USD 0.17  0.01  6.25%   
Below is the normalized historical share price chart for ReShape Lifesciences extending back to October 06, 2016. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of ReShape Lifesciences stands at 0.17, as last reported on the 23rd of April, with the highest price reaching 0.18 and the lowest price hitting 0.17 during the day.
IPO Date
15th of November 2007
200 Day MA
0.4949
50 Day MA
0.1698
Beta
1.296
 
Covid
If you're considering investing in ReShape Stock, it is important to understand the factors that can impact its price. ReShape Lifesciences maintains Sharpe Ratio (i.e., Efficiency) of -0.058, which implies the firm had a -0.058% return per unit of standard deviation over the last 3 months. ReShape Lifesciences exposes twenty-one different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check ReShape Lifesciences' Coefficient Of Variation of (1,172), risk adjusted performance of (0.04), and Market Risk Adjusted Performance of (0.43) to confirm the risk estimate we provide.
  
Common Stock Shares Outstanding is likely to gain to about 6.3 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 6.3 M in 2024. . At this time, ReShape Lifesciences' Price To Sales Ratio is comparatively stable compared to the past year. Price Sales Ratio is likely to gain to 0.34 in 2024, whereas Price Earnings Ratio is likely to drop (0.14) in 2024. ReShape Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.058

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsRSLS

Estimated Market Risk

 4.29
  actual daily
37
63% of assets are more volatile

Expected Return

 -0.25
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.06
  actual daily
0
Most of other assets perform better
Based on monthly moving average ReShape Lifesciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ReShape Lifesciences by adding ReShape Lifesciences to a well-diversified portfolio.
Price Book
0.5798
Enterprise Value Ebitda
0.023
Price Sales
0.4452
Shares Float
20.8 M
Wall Street Target Price
1

ReShape Lifesciences Stock Price History Chart

There are several ways to analyze ReShape Stock price data. The simplest method is using a basic ReShape candlestick price chart, which shows ReShape Lifesciences price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceJanuary 26, 20240.21
Lowest PriceFebruary 23, 20240.15

ReShape Lifesciences April 23, 2024 Stock Price Synopsis

Various analyses of ReShape Lifesciences' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell ReShape Stock. It can be used to describe the percentage change in the price of ReShape Lifesciences from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of ReShape Stock.
ReShape Lifesciences Price Daily Balance Of Power 1.00 
ReShape Lifesciences Accumulation Distribution 5,766 
ReShape Lifesciences Price Rate Of Daily Change 1.06 

ReShape Lifesciences April 23, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in ReShape Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use ReShape Lifesciences intraday prices and daily technical indicators to check the level of noise trading in ReShape Stock and then apply it to test your longer-term investment strategies against ReShape.

ReShape Stock Price History Data

The price series of ReShape Lifesciences for the period between Wed, Jan 24, 2024 and Tue, Apr 23, 2024 has a statistical range of 0.09 with a coefficient of variation of 11.98. The price distribution for the period has arithmetic mean of 0.18. The median price for the last 90 days is 0.17. The company completed stock split (1:50) on 23rd of December 2022. ReShape Lifesciences had dividends distributed to its stock-holders on 2019-07-25.
OpenHighLowCloseVolume
04/22/2024 0.17  0.18  0.17  0.17  103,794 
04/19/2024 0.17  0.18  0.17  0.17  79,632 
04/18/2024 0.17  0.18  0.16  0.17  431,781 
04/17/2024 0.17  0.17  0.16  0.16  272,954 
04/16/2024 0.16  0.17  0.16  0.16  150,245 
04/15/2024 0.17  0.17  0.16  0.16  172,425 
04/12/2024 0.16  0.17  0.16  0.16  199,442 
04/11/2024 0.17  0.17  0.16  0.16  144,257 
04/10/2024 0.18  0.18  0.16  0.17  228,448 
04/09/2024 0.17  0.18  0.16  0.17  174,036 
04/08/2024 0.17  0.17  0.16  0.17  123,188 
04/05/2024 0.17  0.17  0.16  0.17  405,274 
04/04/2024 0.17  0.18  0.17  0.17  134,121 
04/03/2024 0.16  0.21  0.16  0.18  1,873,869 
04/02/2024 0.17  0.18  0.17  0.17  221,734 
04/01/2024 0.16  0.18  0.16  0.16  660,044 
03/28/2024 0.19  0.20  0.18  0.18  756,830 
03/27/2024 0.19  0.19  0.18  0.18  149,312 
03/26/2024 0.18  0.19  0.18  0.18  298,017 
03/25/2024 0.19  0.19  0.19  0.19  470,352 
03/22/2024 0.17  0.19  0.17  0.19  999,886 
03/21/2024 0.17  0.19  0.17  0.18  656,117 
03/20/2024 0.16  0.17  0.16  0.17  355,820 
03/19/2024 0.16  0.17  0.16  0.16  185,050 
03/18/2024 0.17  0.17  0.16  0.16  219,459 
03/15/2024 0.17  0.17  0.16  0.16  234,893 
03/14/2024 0.17  0.18  0.16  0.17  618,905 
03/13/2024 0.17  0.18  0.17  0.17  285,995 
03/12/2024 0.18  0.18  0.16  0.17  598,720 
03/11/2024 0.17  0.19  0.17  0.18  607,434 
03/08/2024 0.17  0.18  0.16  0.17  142,222 
03/07/2024 0.16  0.19  0.15  0.17  1,560,271 
03/06/2024 0.16  0.16  0.15  0.16  306,627 
03/05/2024 0.17  0.17  0.15  0.15  507,127 
03/04/2024 0.16  0.17  0.16  0.16  722,364 
03/01/2024 0.17  0.17  0.16  0.17  162,814 
02/29/2024 0.18  0.18  0.16  0.17  508,782 
02/28/2024 0.17  0.18  0.16  0.17  1,258,356 
02/27/2024 0.16  0.16  0.14  0.16  761,706 
02/26/2024 0.15  0.15  0.15  0.15  348,954 
02/23/2024 0.16  0.16  0.15  0.15  467,037 
02/22/2024 0.17  0.17  0.15  0.16  1,356,898 
02/21/2024 0.16  0.17  0.16  0.17  301,685 
02/20/2024 0.18  0.22  0.16  0.17  2,365,219 
02/16/2024 0.17  0.18  0.17  0.17  178,413 
02/15/2024 0.15  0.18  0.15  0.17  828,610 
02/14/2024 0.16  0.17  0.14  0.16  1,332,584 
02/13/2024 0.19  0.19  0.16  0.17  860,527 
02/12/2024 0.19  0.20  0.18  0.18  688,809 
02/09/2024 0.20  0.20  0.18  0.19  654,057 
02/08/2024 0.20  0.20  0.19  0.20  278,489 
02/07/2024 0.20  0.20  0.19  0.20  277,716 
02/06/2024 0.19  0.20  0.19  0.19  510,332 
02/05/2024 0.20  0.21  0.20  0.20  378,872 
02/02/2024 0.20  0.21  0.19  0.20  446,948 
02/01/2024 0.21  0.21  0.20  0.21  338,311 
01/31/2024 0.20  0.21  0.20  0.21  367,101 
01/30/2024 0.21  0.22  0.21  0.21  295,958 
01/29/2024 0.21  0.22  0.20  0.21  340,539 
01/26/2024 0.20  0.21  0.20  0.21  419,651 
01/25/2024 0.21  0.21  0.20  0.20  853,376 

About ReShape Lifesciences Stock history

ReShape Lifesciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ReShape is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ReShape Lifesciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ReShape Lifesciences stock prices may prove useful in developing a viable investing in ReShape Lifesciences
Last ReportedProjected for Next Year
Common Stock Shares OutstandingM6.3 M
Net Loss-41.6 M-43.7 M

ReShape Lifesciences Stock Technical Analysis

ReShape Lifesciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of ReShape Lifesciences technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of ReShape Lifesciences trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run FinTech Suite Now

   

FinTech Suite

Use AI to screen and filter profitable investment opportunities
All  Next Launch Module

ReShape Lifesciences Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for ReShape Lifesciences' price direction in advance. Along with the technical and fundamental analysis of ReShape Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ReShape to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
When determining whether ReShape Lifesciences is a strong investment it is important to analyze ReShape Lifesciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ReShape Lifesciences' future performance. For an informed investment choice regarding ReShape Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in ReShape Lifesciences. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of economic analysis.
For more information on how to buy ReShape Stock please use our How to Invest in ReShape Lifesciences guide.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for ReShape Stock analysis

When running ReShape Lifesciences' price analysis, check to measure ReShape Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ReShape Lifesciences is operating at the current time. Most of ReShape Lifesciences' value examination focuses on studying past and present price action to predict the probability of ReShape Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ReShape Lifesciences' price. Additionally, you may evaluate how the addition of ReShape Lifesciences to your portfolios can decrease your overall portfolio volatility.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Is ReShape Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ReShape Lifesciences. If investors know ReShape will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ReShape Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.91)
Revenue Per Share
1.457
Quarterly Revenue Growth
(0.36)
Return On Assets
(0.84)
Return On Equity
(2.21)
The market value of ReShape Lifesciences is measured differently than its book value, which is the value of ReShape that is recorded on the company's balance sheet. Investors also form their own opinion of ReShape Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is ReShape Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ReShape Lifesciences' market value can be influenced by many factors that don't directly affect ReShape Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ReShape Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if ReShape Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ReShape Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.